GlassScriptPhysician profile
Nicole A Wolf
NPI 1104365014
$1,382.31
in general payments reported to CMS, 2019-2025
18 companies · $722 in 2025
The $722 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.74 · 2023: $19.99 · 2024: $627 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $278.22 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $212.55 | 2024-2025 | |
| Amgen INC. | $158.18 | 2024-2025 | Repatha, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $133.99 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $94.59 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $82.25 | 2025 | |
| Novo Nordisk INC | $81.59 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.67 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $52.92 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Globus Medical, INC. | $46.15 | 2025 | Senza |
| Takeda Pharmaceuticals U.S.A., INC. | $38.26 | 2025 | Trintellix |
| Lilly USA, LLC | $33.62 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $30.06 | 2024-2025 | Shingrix, Arexvy |
| Eisai INC. | $22.27 | 2025 | |
| Corium, LLC | $20.17 | 2024 | Azstarys |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $15.53 | 2025 | Flucelvax, Fluad |
| Janssen Pharmaceuticals, INC | $13.74 | 2021 | |
| Corcept Therapeutics | $13.55 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.